Bio2040 interviews M4K Pharma’s Owen Roberts [Podcast]

Apr 17

In a podcast interview with Bio2040, CEO Owen Roberts discusses M4K Pharma’s business model and why open science and sharing can be the path to finding medicines for rare diseases like DIPG.

Max Morgan

M4K’s Lemon Face Challenge for DIPG

Redefining Pharmaceutical Innovation Through Open Science

We are transforming how new medicines are developed to address unmet needs in childhood diseases.

Follow us on social media

©M4K Pharma - CC BY 4.0

Terms of Use

                                                       Privacy Policy

Bio2040 interviews M4K Pharma’s Owen Roberts [Podcast]

M4K’s Lemon Face Challenge for DIPG

SGC Open Notebookers Share DIPG Drug Discovery Research in Real Time